(VIANEWS) - Fidelity National Information Services (FIS), Royalty Pharma (RPRX), Cabot Corporation (CBT) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio up until now. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Fidelity National Information Services (FIS)
111.56% Payout Ratio
Fidelity National Information Services, Inc. offers technology solutions to merchants, banks, capital market firms and other organizations worldwide. The company operates in three segments: Merchant Solutions, Banking Solutions and Capital Market Solutions. Merchant Solutions offers global ecommerce, enterprise acquiring and software-led small to medium-sized business acquiring. Core processing and other ancillary services are provided by the Banking Solutions segment. Digital solutions include Internet, mobile and ebanking, fraud, risk management and compliance solutions. Electronic funds transfer and network service is also offered. Card and retail payment options, wealth and retirement strategies, item processing, and output services are all available. Capital Market Solutions offers corporate liquidity, securities processing, finance, global trading and asset management, as well as solutions for corporate liquidity. Fidelity National Info Services, Inc. was established in 1968. It is located in Jacksonville, Florida.
Earnings per Share
Fidelity National Information Services' trailing twelve-month EPS is $0.25.
PE Ratio
Fidelity National Information Services' trailing 12 months earnings to price ratio is 281.58. The purchaser of the shares is investing $281.58 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 1.91%.Sales Growth
Fidelity National Information Services has experienced a 8% sales increase in the most recent quarter.
Moving Average
Fidelity National information Services's value has fallen way below its $50-day moving mean of $81.29, and far below its $200-day moving median of $95.09.Revenue growth
The year-on-year revenue growth was 8.3%. We now have 14.15B in the 12 trailing months.
Yearly Top and Bottom Value
Fidelity National Information Services's stock is valued at $70.39 at 01:23 EST, way under its 52-week high of $122.06 and way higher than its 52-week low of $56.53.
2. Royalty Pharma (RPRX)
69.9% Payout Ratio
Royalty Pharma plc is a purchaser of biopharmaceutical royalty and a financier of innovation in the US biopharmaceutical sector. The company is involved in the acquisition, evaluation and identification of royalties for various biopharmaceutical treatments. The company also collaborates with researchers from universities, hospitals, not-for profit organizations, small- and medium-cap biotechnology firms, as well as pharmaceutical companies. The company's portfolio includes royalties from approximately 35 commercially available therapies as well as 10 early-stage products that target various therapeutic areas such rare diseases, cancer, neurology and infectious disease. It was established in New York in 1996.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $1.93.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 21.7. Meaning, the purchaser of the share is investing $21.7 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.6%.Moving Average
Royalty Pharma's worth is below its 50-day moving average of $41.98 and above its 200-day moving average of $41.45.Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 16, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 1.83%.
Growth Estimates Quarters
For the current quarter, the company expects a decline of 2.7% in growth and a rise of 22.5% the following.Annual Top and Bottom Value
Royalty Pharma stock was valued at $41.79 as of 01:26 EST. This is below the 52-week high at $44.75, and much higher than the 52-week low at $36.15.
3. Cabot Corporation (CBT)
40.88% Payout Ratio
Cabot Corporation is a company that produces specialty chemicals and other performance materials. The company operates in three main segments, Reinforcement Materials and Performance Chemicals. It offers rubber reinforcing agents and performance additives for tires, along with hoses and belts and extruded profile and molded products. The company also offers specialty carbons for inks and coatings. The company also offers activated-carbon products for purification of water and air as well as pharmaceuticals and other liquids. It sells products via distributors in Europe, Asia Pacific, Africa, Middle East and Africa. Cabot Corporation was established in Boston in 1882.
Earnings per Share
Cabot Corporation's trailing 12 month EPS is $3.62.
PE Ratio
Cabot Corporation's trailing 12-month price-to-earnings ratio is 19.73. The purchaser of the shares is therefore investing $19.73 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 22.9%.Moving Average
Cabot Corporation is worth more than its moving average for 50 days of $69.90, and its moving average for 200 days of $69.82.Earnings before Interest, Taxes and Depreciation
Cabot Corporation's EBITDA stands at 1.28
4. Arrow Financial Corporation (AROW)
35.32% Payout Ratio
Arrow Financial Corporation is a bank holding firm that provides financial services and commercial banking. Deposit products of the company include time deposits and time deposits. The company's lending activities include commercial loans such as time notes and term loans; commercial real estate loans that finance commercial property purchases, refinance, expansions, or improvements, as well commercial construction loans and loans for land development to finance project financing. It also offers consumer installment loans for personal expenses, such as overdraft protection and personal credit cards; residential real estate loans and fixed home equity loans. These loans can be used to fund home improvement, consolidation and education. It also maintains an indirect loan program and offers residential mortgage loans to the secondary market. The company also offers retirement planning and trust services; as well as pension, profit-sharing and corporate benefit plan administration services. It also offers services as an insurance agent, including group insurance policies, life insurance and property and casualty products. The company also provides investment advisory services for its mutual funds and a trust that holds real estate investments. It operates in New York's northeastern regions, including Warren, Washington and Schenectady, in Saratoga, Essex as well as in Rensselaer, Albany and Schenectady. The company owns 27 branch banks offices and leases 13 branch offices. There are also two residential loan origination centers. Arrow Financial Corporation was established in Glens Falls in New York in 1851.
Earnings per Share
Arrow Financial Corporation's trailing 12 months profit per share is $2.96
PE Ratio
Arrow Financial Corporation's trailing 12-month price-earnings ratio is 11.95. The purchaser of the shares is therefore investing $11.95 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 13.49%.Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 29, 2022, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 3.37%.